HIV resistance and the effectiveness of combination antiretroviral treatment
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Therapeutic Strategies
- Vol. 1 (4) , 529-535
- https://doi.org/10.1016/j.ddstr.2004.11.006
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Weighted Phenotypic Susceptibility Scores Are Predictive of the HIV‐1 RNA Response in Protease Inhibitor–Experienced HIV‐1–Infected SubjectsThe Journal of Infectious Diseases, 2004
- Treatment for Adult HIV InfectionJAMA, 2004
- Where Does HIV Live?New England Journal of Medicine, 2004
- Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 InfectionNew England Journal of Medicine, 2004
- Paradoxes of adherence and drug resistance to HIV antiretroviral therapyJournal of Antimicrobial Chemotherapy, 2004
- HIV Drug ResistanceNew England Journal of Medicine, 2004
- Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patientsAIDS, 2004
- Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patientsJournal of Antimicrobial Chemotherapy, 2003
- Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugsAIDS, 2003
- Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in AdultsNew England Journal of Medicine, 1999